Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FQ64Q
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,670
Award facts
- Contract value 100% obligated
- $4,670.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,670.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 2, 2025, for the supply of TYMLOS 80 MCG Dose Pen Injector (1.56ML). This delivery order, which must be completed by September 3, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order from its location in the same city. The company serves as a critical supplier within the federal pharmaceutical supply chain, providing prescription medications and medical supplies to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion vehicle valid through November 2026. This IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide, encompassing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. TYMLOS, an abaloparatide injection used to treat osteoporosis in postmenopausal women, represents one of many specialized pharmaceutical products the contractor supplies through this strategic partnership with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FQ64Q?
SPE2DB25FQ64Q was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FQ64Q worth?
The government has obligated $4,670 on SPE2DB25FQ64Q.
Is contract SPE2DB25FQ64Q an order under another contract?
Yes. SPE2DB25FQ64Q is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FQ64Q competed?
The extent of competition for SPE2DB25FQ64Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award